From Name:
From Email:
To Name:
To Email:

Optional Message:

ASCO issues guideline on biomarker-based adjuvant breast cancer treatment

from Cancer Network

The American Society of Clinical Oncology (ASCO) has published a guideline on biomarker use to guide decisions for adjuvant systemic treatment for women with early-stage, invasive breast cancer. The guideline was published in the Journal of Clinical Oncology. Besides the use of assays to identify women with estrogen receptor (ER)- and/or progesterone receptor (PR)-positive or human epidermal growth factor receptor 2 (HER2)-positive diseases, the authors found satisfactory clinical trial data and prospective-retrospective studies to recommend the use of six biomarker assays in specific patient subgroups. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063